John Bernard Payne - Net Worth and Insider Trading

John Bernard Payne Net Worth

The estimated net worth of John Bernard Payne is at least $12,332 dollars as of 2024-05-21. John Bernard Payne is the President and CEO of Zivo Bioscience Inc and owns about 1,567 shares of Zivo Bioscience Inc (ZIVO) stock worth over $12,332. Details can be seen in John Bernard Payne's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Bernard Payne has not made any transactions after 2022-12-19 and currently still holds the listed stock(s).

Transaction Summary of John Bernard Payne

To

John Bernard Payne Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Bernard Payne owns 2 companies in total, including Nexvet Biopharma PLC (NVET) , and Zivo Bioscience Inc (ZIVO) .

Click here to see the complete history of John Bernard Payne’s form 4 insider trades.

Insider Ownership Summary of John Bernard Payne

Ticker Comapny Transaction Date Type of Owner
NVET Nexvet Biopharma PLC 2017-07-31 director
ZIVO Zivo Bioscience Inc 2022-12-19 director

John Bernard Payne Latest Holdings Summary

John Bernard Payne currently owns a total of 1 stock. John Bernard Payne owns 1,567 shares of Zivo Bioscience Inc (ZIVO) as of December 19, 2022, with a value of $12,332.

Latest Holdings of John Bernard Payne

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZIVO Zivo Bioscience Inc 2022-12-19 1,567 7.87 12,332

Holding Weightings of John Bernard Payne


John Bernard Payne Form 4 Trading Tracker

According to the SEC Form 4 filings, John Bernard Payne has made a total of 2 transactions in Zivo Bioscience Inc (ZIVO) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Zivo Bioscience Inc is the acquisition of 10 shares on December 19, 2022, which cost John Bernard Payne around $143.

Insider Trading History of John Bernard Payne

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Bernard Payne Trading Performance

GuruFocus tracks the stock performance after each of John Bernard Payne's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Bernard Payne is 25.1%. GuruFocus also compares John Bernard Payne's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Bernard Payne within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John Bernard Payne's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John Bernard Payne

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.56
Relative Return to S&P 500(%) 22.83

John Bernard Payne Ownership Network

Ownership Network List of John Bernard Payne

No Data

Ownership Network Relation of John Bernard Payne


John Bernard Payne Owned Company Details

What does Nexvet Biopharma PLC do?

Who are the key executives at Nexvet Biopharma PLC?

John Bernard Payne is the director of Nexvet Biopharma PLC. Other key executives at Nexvet Biopharma PLC include 10 percent owner & other: Member of Group Owning 10% Philip D Dreyfuss , 10 percent owner & other: Member of Group Owning 10% William Seybold , and 10 percent owner & other: Member of Group Owning 10% Ravi K Paidipaty .

Nexvet Biopharma PLC (NVET) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nexvet Biopharma PLC (NVET) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nexvet Biopharma PLC (NVET) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nexvet Biopharma PLC (NVET)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nexvet Biopharma PLC Insider Transactions

No Available Data

John Bernard Payne Mailing Address

Above is the net worth, insider trading, and ownership report for John Bernard Payne. You might contact John Bernard Payne via mailing address: 9900 Ne 114th Circle, Vancouver Wa 98662.

Discussions on John Bernard Payne

No discussions yet.